Synthesis and angiogenetic activity in the chick chorioallantoic membrane model of thymosin beta-15

Peptides

Volumn 24, Issue 1, 2003, Pages 107-115

  Koutrafouri, Vassiliki ^a,b   Leondiadis, Leondios ^b   Ferderigos, Nikolas ^c   Avgoustakis, Konstantinos ^a   Livaniou, Evangelia ^b   Evangelatos, Gregory P ^b   Ithakissios, Dionyssis S ^a,b  

^a UNIVERSITY OF PATRAS   (Greece)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Angiogenesis; CAM; Fmoc solid phase peptide synthesis; P Cyanotrityl resin; Thymosin beta 15

Indexed keywords

ANGIOGENIC FACTOR; PHORBOL 12 ACETATE 13 MYRISTATE; RESIN; THYMOSIN BETA15; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ANGIOGENESIS; ARTICLE; BIOLOGICAL MODEL; BREAST CANCER; CANCER TISSUE; CHICKEN; CHORIOALLANTOIS; CONCENTRATION RESPONSE; DRUG SYNTHESIS; HUMAN; IN VIVO STUDY; MASS SPECTROMETRY; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION; PROTEIN STABILITY; PROTEIN STRUCTURE;

ALLANTOIN; AMINO ACID SEQUENCE; ANIMALS; CHICK EMBRYO; CHORION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; THYMOSIN;

EID: 0037255905     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00282-6     Document Type: Article

References (39)

1. Bao L., Loda M., Janmey P.A., Stewart R., Anand-Apte B., Zetter B.R. Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Nat. Med. 2(12):1996;1322-1328.
2. Bao L., Loda M., Zetter B.R. Thymosin β15 expression in tumor cell lines with varying metastatic potential. Clin. Exp. Metastasis. 16:1998;227-233.
3. Bao L., Zetter B.R. Molecular cloning and structural characterization of the rat thymosin β15 gene. Gene. 260:2000;37-44.
4. Califano D., Monaco C., Santelli G., Giuliano A., Veronese M.L., Berlingieri M.T.et al. Thymosin β10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro. Cancer Res. 58:1998;823-828.
5. Chakravatri A., Zehr E.M., Zietman A.L., Shipley W.U., Goggins W.B., Finkelstein D.M.et al. Thymosin β15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study. Urology. 55:2000;635-638.
6. Eadie J.S., Kim S.W., Allen P.G., Hutchinson L.M., Kantor J.D., Zetter B.R. C-terminal variations in β-thymosin family members specify functional differences in actin-binding properties. J. Cell Biochem. 77:2000;277-287.
7. Fields G.B., Noble R.L. Solid phase synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35(3):1990;161-214.
8. Folkman J. Tumor angiogenesis. Adv. Cancer Res. 43:1985;175-203.
9. Frohm M., Gunne H., Bergman A.C., Agerberth B., Bergman T., Boman A.et al. Biochemical and antibacterial analysis of human wound and blister fluid. Eur. J. Biochem. 237:1996;86-92.
10. Gold J.S., Bao L., Ghoussoub R.A.D., Zetter B.R., Rimm D.L. Localization and quantitation of expression of the cell motility-related protein thymosin β15 in human breast tissue. Modern Pathol. 10:1997;1106-1112.
11. Gomez-Marquez J., Franco Del Amo F., Carpintero P., Anadon R. High levels of mouse thymosin β4 mRNA in differentiating p19 embryonic cells and during development of cardiovascular tissues. Biophys. Biochim. Acta. 1306:1996;187-193.
12. Grant D.S., Kinsella J.L., Kibbey M.C., Laflamme S., Burbelo P.D.et al. Matrigel induces thymosin β4 gene in differentiating endothelial cells. J. Cell Sci. 108:1995;3685-3694.
13. Hannappel E., Wartenberg F. Actin-sequestering ability of thymosin β4, thymosin β4 fragments, and thymosin β4-like peptides as assessed by the DNAase I inhibition assay. Biol. Chem. 374:1993;117-122.
14. Haritos A.A., Goodall G.J., Horecker B.L. Prothymosin α: isolation and properties of the major immunoreactive form of thymosin α1 in rat thymus. Proc. Natl. Acad. Sci. USA. 81:1984;1008-1011.
15. Harris-Hooker S.A., Gajdusek C.M., Wight T.N., Schwartz S.M. Neovascular responses induced by cultured aortic endothelial cells. J. Cell Physiol. 114:1983;302-310.
16. Heintz D., Reichert A., Mihelic M., Voelter W., Faulstich H. Use of bimanyl actin derivative (TMB-actin) for studying complexation of beta-thymosins. Inhibition of actin polymerization by thymosin beta 9. FEBS L. 329:1993;9-12.
17. Huang W.Q., Wang Q.R. Bone marrow endothelial cells secrete thymosin β4 and AcSDKP. Exp Hematol. 29:2001;12-18.
18. Huff T., Muller C.S.G., Otto A.M., Netzker R., Hannappel E. β-Thymosins, small acidic peptides with multiple functions. Int. J. Biochem. Cell Biol. 33:2001;205-220.
19. Huff T., Otto A.M., Muller C.S.G., Meier M., Hannappel E. Thymosin β4 is released from human blood platelets and attached by factor XIIIa (trans-glutaminase) to fibrin and collagen. FASEB J. 16:2002;691-696.
20. Kent SBH. Peptides, structure and function. In: Deber CM, Hruby VJ, Kopple KD, editors. Proceedings of the 9th American Peptide Symposium, Pierce Chemical Co., Rockford, IL, USA; 1985. p. 407-14.
21. Koutrafouri V., Leondiadis L., Avgoustakis K., Livaniou E., Czarnecki J., Ithakissios D.S.et al. Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model. BBA. 1568:2001;60-66.
22. Leondiadis L., Vassiliadou I., Zikos C., Ferderigos N., Livaniou E., Ithakissios D.S.et al. Solid-phase synthesis of thymosin β10 using a p-cyanotrityl resin. Chemical characterization and immunochemical control of the synthetic peptide. J. Chem. Soc. Perkin Trans. 1:1996;971-975.
23. Lin S.-C., Morrison-Bogorad M. Developmental expression of mRNAs encoding thymosins β4 and β10 in rat brain and other tissues. J. Mol. Neurosci. 2:1990;35-44.
24. Lutz W. In: Weir DM, editor. Handbook of experimental immunology, 3rd ed. Oxford, London, Edinburg, Melburne: Blackwell Scientific Publications; 1978. p. 1-29.
25. Malinda K.M., Sidhu G.S., Mani H., Maheshwari R.K., Goldstein A.L., Kleinman H.K. Thymosin β4 accelerates wound healing. J. Invest. Dermatol. 113(3):1999;364-368.
26. Malinda K.M., Goldstein A.L., Kleinman H.K. Thymosin β4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J. 11:1997;474-481.
27. Maragoudakis M.E., Panoutsakopoulou M., Sarmonica M. Rate of basement membrane biosynthesis as an index to angiogenesis. Tissue & Cell. 20:1988;531-539.
28. Montesano R., Orci L. Phorbol esters induce angiogenesis in vitro from large-vessel endothelial cells. J. Cell. Physiol. 130(2):1987;284-291.
29. Nehls V., Drenckhahn D. A novel microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc. Res. 50:1995;311-322.
30. Roboti A., Livaniou E., Evangelatos G.P., Tsoupras G., Tsolas O., Ithakissios D.S. Large-scale chromatofocusing-based method for isolating thymosin β4 and thymosin β9 from bovine tissues. J. Chromatogr. B Biomed. Sci. Appl. 662:1994;27-34.
31. Safer D., Golla R., Nachmias V.T. Isolation of a 5-kilodalton actin-sequestering peptide from human blood platelets. Proc. Natl. Acad. Sci. USA. 87:1990;2536-2540.
32. Schefler WC. Statistics in biological science. In: Reading MA, editor. Meulo Park, CA, London, Don Mills, Ontario: Addison-Wesley Publishing Company; 1969. p. 68-85.
33. Sun H.-Q., Kwiatkowska K., Yin H.L. Actin monomer binding proteins. Curr. Opin. Cell Biol. 7:1995;102-110.
34. Vassiliadou I, Costopoulou D, Czarnecki J, Leondiadis L, Livaniou E, Ferderigos N, Ithakissios DS, Evangelatos GP. Synthesis of amino- and carboxy-terminal fragments of prothymosin α and development of anti-peptide antisera specific for the intact molecules. In: Ramage R, Epton R, editors. Proceedings of the 24th European Peptides Symposium, Mayflower Scientific Ltd.; 1996. p. 865-6.
35. Verghese-Nikolakaki S., Apostolikas N., Livaniou E., Ithakissios D.S., Evangelatos G.P. Preliminary findings on the expression of thymosin β10 in human breast cancer. Br. J. Cancer. 74:1996;1441-1444.
36. Weterman M.A., van-Muijen G.N., Ruiter D.J., Bloemers H.P. Thymosin β10 expression in melanoma cell lines and melanocytic lesions: a new progression marker for human cutaneous melanoma. Int. J. Cancer. 53:1993;278-284.
37. Yialouris P.P., Coles B., Tsitsiloni O., Schmid B., Howell S., Aitken A.et al. The complete sequences of trout Salmo gairdneri thymosin beta 11 and its homologue thymosin beta 12. Biochem. J. 283:1992;385-389.
38. Young J.D., Lawrence A.J., MacLean A.G., Leung B.P., McInnes I.B., Canas B.et al. Thymosin β4-sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nature Med. 5:1999;1424-1427.
39. Yu F.-X., Lin S.-C., Morrison-Bogorad M., Atkinson M.A.L., Yin H.L. Thymosin β10 and thymosin β4 are both monomer sequestering proteins. J. Biol. Chem. 268:1993;502-509.